GL1X · GenesisL1 explorer

Research workbench

Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor

Analyse Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1NHU
Type
protein
Length
1,115 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase
EC
2.7.7.48
UniProt
P26663
Ligands
153
Pockets
13 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatitis C virus NS5B RNA-dependent RNA polymerase (EC 2.7.7.48)protein55849% helix, 15% strandP26663
BHepatitis C virus NS5B RNA-dependent RNA polymerase (EC 2.7.7.48)protein55749% helix, 15% strandP26663

Ligands and binding sites

  • 153 · (2S)-2-[(2,4-dichloro-benzoyl)-(3-trifluoromethyl-benzyl)-amino]-3-phenyl-propionic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111300.800.8190empty
210900.800.8177empty
39680.740.7753empty
4960.510.8317empty
51100.490.8021empty

Interfaces

1 interface between chains.

  • A–B · 443 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 1NHU · Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.